NextWave Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
NextWave Pharmaceuticals, Inc. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include QUILLICHEW, QUILLIVANT, QUILLICHEW ER, and QUILLIVANT XR. The owner is based in Cupertino, CA.
Suite 150
20450 Stevens Creek Boulevard
Cupertino, CA 95014
Showing of trademarks Trademarks
Trademark Classifications
NextWave Pharmaceuticals, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does NextWave Pharmaceuticals, Inc. have?
NextWave Pharmaceuticals, Inc. has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 4 abandoned, 2 cancelled.
What trademark classes does NextWave Pharmaceuticals, Inc. file in?
NextWave Pharmaceuticals, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are NextWave Pharmaceuticals, Inc.'s most well-known trademarks?
NextWave Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as QUILLICHEW, QUILLIVANT, QUILLICHEW ER, and QUILLIVANT XR. These are among 4 currently registered trademarks in the portfolio.
What is NextWave Pharmaceuticals, Inc.'s trademark registration success rate?
NextWave Pharmaceuticals, Inc. has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.